Search

everythinglearnresearchcommunity

for

Search:↓

Understanding how Regulatory T Cells work could help create treatments for certain skin diseases and cancers.

Chemotherapy side effects might help treat autoimmune hair loss.

Auto-antibody testing is a useful but not definitive tool in diagnosing interstitial lung diseases, and using a specific algorithm could make testing more cost-effective.

Hydroxychloroquine is most effective for scarring alopecias, especially when combined with other treatments.

Many children with alopecia areata also have other autoimmune diseases.

Skin and mucous symptoms are key for diagnosing autoimmune connective tissue diseases.

People with chronic hives should be tested for thyroid autoimmunity to manage their condition better.

Cyclophosphamide has serious side effects, but long-term follow-up can help manage risks.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

Alfredo Rebora suggested a new, easier way to classify hair loss in Telogen Effluvium, adding a type possibly related to autoimmune diseases.

Hair loss in Telogen effluvium is often chronic, linked to stress, and lacks a confirmed treatment, but topical corticosteroids may be used.

Alfredo Rebora suggests a simpler classification for hair loss and a new test for easier diagnosis.

CD44 variant changes start alopecia areata, but don't maintain it.

Higher testosterone levels can increase the risk of certain diseases like type 2 diabetes in women and prostate cancer in men, but can also protect against autoimmune diseases and hair loss. It also affects body fat and bone density.

Autoimmune reactions may cause both alopecia areata and HAM.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.

Human hair shows promise for non-invasive medical testing, but more research is needed to standardize its use.

Tofacitinib helped improve symptoms and hair growth in a patient with Aicardi-Goutières syndrome.

ITK inhibitors may effectively treat alopecia areata.

Autoimmune diseases can change hair texture, but treatment can restore it.

Dermatologists vary widely in testing practices for alopecia areata, often exceeding guideline recommendations.

The model helps understand alopecia areata and suggests ways to improve treatment by targeting immune issues.

Stress can cause a type of hair loss in mice lacking the CCHCR1 gene.

Hydroxychloroquine may cause false results in tuberculosis tests for patients with autoimmune skin diseases.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

OX40-targeted therapies may help treat skin diseases by reducing inflammation and balancing immune responses.

Some people with chronic hair loss may have thyroid autoimmunity.

Anesthesia and surgery can cause temporary hair loss, but hair usually grows back without treatment.

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.